Doctor Mich Erlewyn-Lajeunesse | University of Southampton

Publications

48 publications

Page 2 of 5

Language that disempowers patients: the doctor is the poor historian

Mich Lajeunesse, 2022, BMJ (Clinical research ed.), 377

Type: letterEditorial

Duck egg tolerance in children with hen’s egg allergy

Jennifer Elliott, Stephanie Cross, Zaraquiza Zolkipli, Emma Grainger‐Allen, Charles Powell, June Abayasiriwardana & Michel Erlewyn‐Lajeunesse, 2021, Clinical & Experimental Allergy, 51(11), 1519-1522

DOI: 10.1111/cea.14012

Type: letterEditorial

BSACI 2021 guideline for the management of egg allergy

Susan C. Leech, Pamela W. Ewan, Isabel J. Skypala, Nicola Brathwaite, Mich Erlewyn‐Lajeunesse, Sarah Heath, Heidi Ball, Polly James, Karen Murphy & Andrew T. Clark, 2021, Clinical & Experimental Allergy, 51(10), 1262-1278

DOI: 10.1111/cea.14009

Type: article

BSACI Registry for Immunotherapy (BRIT): providing safe and effective immunotherapy for allergies and urticaria

Sujoy Khan, Mamidipudi Thirumala Krishna, Louise J. Michaelis, Tom C. Dawson, Deborah Marriage, Anna Thursby‐Pelham, Leyla Pur Özyiğit, Carla Jones, Lynne Regent & Mich Erlewyn‐Lajeunesse, 2021, Clinical & Experimental Allergy, 51(8), 985-988

DOI: 10.1111/cea.13887

Type: article

Using national registries to identify targeted therapies for refractory urticaria

Sujoy Khan, Louise J. Michaelis, Tom C. Dawson, Anna Thusby-Pelham, Leyla Pur Özyiğit, Mamidipudi Thirumala Krishna & Mich Erlewyn-Lajeunesse, 2021, International Archives of Allergy and Immunology, 182(5), 459-460

DOI: 10.1159/000514689

Type: letterEditorial

False tolerant food challenges in children with food protein-induced enterocolitis syndrome

Gabriella Weisz, Stephanie Cross, Kate Grimshaw & Michel Erlewyn-Lajeunesse, 2021, The journal of allergy and clinical immunology. In practice, 9(3), 1418

DOI: 10.1016/j.jaip.2020.12.044

Type: letterEditorial

Anaphylaxis refractory to intra-muscular adrenaline during in-hospital food challenges

C Alviani, S Burrell, A Macleod, S Edees, G Roberts, P J Turner & M Erlewyn-Lajeunesse, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 50(12), 1400-1405

DOI: 10.1111/cea.13749

Type: article

Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

Jonathan O'B. Hourihane, Kristen Beyer, Allyah Abbas & Michel D.S. Erlewyn-Lajeunesse, 2020, The Lancet Child & Adolescent Health, 4(10)

DOI: 10.1016/s2352-4642(20)30234-0

Type: article

Further considerations for venom immunotherapy following the withdrawal of Pharmalgen

M Erlewyn-Lajeunesse, C Alviani, S Cross & E Grainger-Allen, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 50(9), 1111-1112

DOI: 10.1111/cea.13690

Type: article

Allergen Immunotherapy in the era of SARS-CoV-2.

E Compalati, M Erlewyn-Lajeunesse, Ali FR, Fernández P Ojeda, Nuñez I Garcia, F Frati & G Mistrello, 2020, Journal of Investigational Allergology & Clinical Immunology

DOI: 10.18176/jiaci.0568

Type: article

Dr Mich Erlewyn-Lajeunesse

Connect with Mich

Publications